An Orientation to the Standards for the Safe and Effective Provision of Opioid Agonist Maintenance Treatment

Successful completion of the program An Orientation to the Standards for the Safe and Effective Provision of Opioid Agonist Maintenance Treatment is a requirement for all pharmacists who wish to apply for authorization to participate in the provision of opioid agonist maintenance treatment (OAMT) in Newfoundland and Labrador.

The program describes the minimum expectations for pharmacists involved in OAMT as detailed in the NLPB Standards for the Safe and Effective Provision of Opioid Agonist Maintenance Treatment.  The Standards are intended to promote consistency in the provision of this service to the people of this province.

The post-test for this program is based on both the content of the modules as well as the learning activities. A passing grade is 70% or above.

Program Overview

• Introduction
• Purpose of Standards of Practice
• Ethical Considerations
• Requirements of Registrants
• Operational Requirements
• General Practice Standards
• Treatment Choices
• Practice Standards Specific to the Provision of Methadone
• Practice Standards Specific to the Provision of Buprenorphine/Naloxone
• Practice Standards Specific to the Provision of Slow-Release Oral Morphine
• Responding to Special Circumstances
• Ensuring Continuity of Care

Learning Objectives

After completing this program, the participant will be able to:

• Define the purpose of the Standards for Safe and Effective Provision of OAMT
• Apply the NLPB Code of Ethics when making decisions regarding OAMT participation
• Explain the requirements for pharmacy professionals who wish to participate in OAMT services
• Describe the operational standards that must be in place in order for a pharmacy to register for OAMT services
• Describe the general and specific practice standards that pharmacy professionals must adhere to when providing OAMT treatments such as buprenorphine/naloxone, methadone, and slow release oral morphine.
• Navigate clinical practice guidelines for treatment of opioid use disorder to inform clinical decisions related to provision of OAMT.
• Describe how to respond to special circumstances such as intoxication or sedation, partial consumption of doses, and missed doses.
• Ensure continuity of care based on an understanding of the use of a secondary pharmacy or guest dosing, and provision of OAMT in hospitals.

Accreditation

Accredited by the Newfoundland and Labrador Pharmacy Board for 5 CEUs

Accreditation Number:  NL20230719

Accreditation Expiry:  April 30, 2024